Edition:
United Kingdom

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

1.67USD
14 Jun 2019
Change (% chg)

$-0.08 (-4.57%)
Prev Close
$1.75
Open
$1.78
Day's High
$1.80
Day's Low
$1.51
Volume
42,176
Avg. Vol
24,388
52-wk High
$3.75
52-wk Low
$1.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.263
FY 2018 Dec '18 0.00 -0.235
Sep '18 0.00 -0.152
Jun '18 0.00 -0.216
Mar '18 0.00 -0.292
FY 2017 Dec '17 0.00 -0.215
Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 2 0.00 0.00 0.00 --
Quarter Ending Sep-19 2 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Year Ending Dec-20 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-19 5 -0.21 -0.19 -0.22 -0.20
Quarter Ending Sep-19 5 -0.15 -0.12 -0.20 -0.20
Year Ending Dec-19 5 -0.78 -0.69 -0.85 -0.79
Year Ending Dec-20 5 -0.72 -0.65 -0.79 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.55
P/E High - Last 5 Yrs. -- 43.17 48.11
P/E Low - Last 5 Yrs. -- 22.71 23.41
Beta -- 0.86 0.87
Price to Sales (TTM) -- 6.59 8.43
Price to Book (MRQ) 8.59 5.12 5.27
Price to Tangible Book (MRQ) 36.95 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions 5.56 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.71
Payout Ratio(TTM) -- 42.19 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.04
Sales - 5 Yr. Growth Rate -- 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 32.20 46.17 48.21
EPS (TTM) vs TTM 1 Yr. Ago -42.53 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.46
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 1.97 2.87 2.98
LT Debt to Equity (MRQ) 0.00 8.87 11.35
Total Debt to Equity (MRQ) 14.45 12.87 16.04
Interest Coverage (TTM) -2.14 32.47 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.11 52.39
Gross Margin - 5 Yr. Avg. -- 49.67 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.26 12.41
Operating Margin (TTM) -- 13.53 5.67
Operating Margin - 5 Yr. Avg. -- 13.69 8.00
Pre-Tax Margin (TTM) -- 11.88 4.69
Pre-Tax Margin - 5 Yr. Avg. -- 14.09 8.28
Net Profit Margin (TTM) -- 8.79 1.42
Net Profit Margin - 5 Yr. Avg. -- 10.58 4.69
Effective Tax Rate (TTM) -- 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 928,393,106 819,596,351
Net Income/Employee (TTM) -- 105,138,317 92,773,650
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.42
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -186.57 10.98 10.65
Return on Assets - 5 Yr. Avg. -- 12.41 11.77
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -- 15.46 15.24
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -264.31 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -19.33 -22.11 4 30
13 Week -2.45 -7.20 47 42
26 Week -9.01 -15.93 40 43
52 Week -- -- -- 11
YTD -24.26 -33.49 19 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.14%
# of Holders: 19
Total Shares Held: 2,767,337
3 Mo. Net Change: 6,092
# New Positions: 4
# Closed Positions: 4
# Increased Positions: 6
# Reduced Positions: 7
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.